ESR1 and breast cancer: According to the molecular classification, triple-negative breast cancer (TNBC) is defined as an estrogen receptor α (ERα)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor-2 (HER2)-negative disease, which represents 12–17% of all breast cancers [3].